Dental implants in the diabetic patient: systemic and rehabilitative considerations.

Quintessence Int

High-Risk Patient Dental Clinic, Barzilai Medical Center, Ashkelon, Israel.

Published: September 2009

Diabetes mellitus is the most prevalent endocrine disease, comprising the third highest cause of disability and morbidity in the Western world. In the past, implant placement was contraindicated in diabetic patients because of increased risk for implant failure and infection. Publications in recent years have shown success rates for dental implants in diabetic patients resembling those of the general population. Other studies, in diabetic patients, as well as in animal models, have shown an increased risk for implant failure. These results raise the question of whether diabetic patients are suitable for dental implant rehabilitation. This article reviews the literature and presents the factors used in assessing the severity of diabetes and its complications, as well as the considerations for rehabilitation planning in these patients. Integration of these factors by the dentist dictates whether as well as what type of implant-supported restoration should be preformed.

Download full-text PDF

Source

Publication Analysis

Top Keywords

diabetic patients
16
dental implants
8
implants diabetic
8
increased risk
8
risk implant
8
implant failure
8
diabetic
5
patients
5
diabetic patient
4
patient systemic
4

Similar Publications

Background: Adolescent diabetes is one of the major public health problems worldwide. This study aims to estimate the burden of type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM) in adolescents from 1990 to 2021, and to predict diabetes prevalence through 2030.

Methods: We extracted epidemiologic data from the Global Burden of Disease (GBD) on T1DM and T2DM among adolescents aged 10-24 years in 204 countries and territories worldwide.

View Article and Find Full Text PDF

Glucagon: a potential protective factor against peripheral nerve compromise in patients with type 2 diabetes and obesity.

Diabetol Metab Syndr

January 2025

Department of Endocrinology, Affiliated Hospital 2 of Nantong University, and First People's Hospital of Nantong City, No.666 Shengli Road, Nantong, 226001, China.

Background: Increased glucagon levels are now recognized as a pathophysiological adaptation to counteract overnutrition in type 2 diabetes (T2D). This study aimed to elucidate the role of glucagon in peripheral nerve function in patients with T2D with different body mass indices (BMIs).

Methods: We consecutively enrolled 174 individuals with T2D and obesity (T2D/OB, BMI ≥ 28 kg/m), and 480 individuals with T2D and nonobesity (T2D/non-OB, BMI < 28 kg/m), all of whom underwent oral glucose tolerance tests to determine the area under the curve for glucagon (AUC).

View Article and Find Full Text PDF

Studies have shown that the prognosis of dental implant treatment in patients with diabetes is not as good as that in the non-diabetes population. The nerve plays a crucial role in bone metabolism, but the role and the mechanism of peripheral nerves in regulating peri-implant osteogenesis under Type 2 diabetes mellitus (T2DM) situation remains unclear. In this study, it was shown that high glucose-stimulated Schwann cells (SCs) inhibited peri-implant osteogenesis via their exosomes.

View Article and Find Full Text PDF

Background: Anthracycline usage has been linked to cardiovascular adverse events (CAEs), which is unpredictable. It is critical to identify the characteristics of vulnerable populations and risk factors in order to reduce the occurrence of CAEs.

Objectives: This meta-analysis aimed to assess the correlation between various risk factors and CAEs induced by anthracyclines.

View Article and Find Full Text PDF

Background: Cytomegalovirus (CMV) can cause life-threatening diseases in immunosuppressed patients. Some of the patients with connective tissue disease develop CMV infection, and approximately half of this group has been reported to have received pulsed-methylprednisolone (p-MPSL) therapy. This study aimed to identify predictors of the onset of CMV infection in patients receiving p-MPSL therapy for connective tissue disease.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!